These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 16968467
1. Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. Shyu KG, Lu MJ, Wang BW, Sun HY, Chang H. Eur J Clin Invest; 2006 Oct; 36(10):713-9. PubMed ID: 16968467 [Abstract] [Full Text] [Related]
2. Carvedilol modulates the expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in a rat model of volume-overload heart failure. Shyu KG, Lu MJ, Chang H, Sun HY, Wang BW, Kuan P. J Card Fail; 2005 Mar; 11(2):152-9. PubMed ID: 15732037 [Abstract] [Full Text] [Related]
3. Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart. Shyu KG, Liou JY, Wang BW, Fang WJ, Chang H. J Biomed Sci; 2005 Mar; 12(2):409-20. PubMed ID: 15942707 [Abstract] [Full Text] [Related]
4. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart. Sun YL, Hu SJ, Wang LH, Hu Y, Zhou JY. Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):553-60. PubMed ID: 16026515 [Abstract] [Full Text] [Related]
5. Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding. Massart PE, Donckier J, Kyselovic J, Godfraind T, Heyndrickx GR, Wibo M. Hypertension; 1999 Dec; 34(6):1197-201. PubMed ID: 10601118 [Abstract] [Full Text] [Related]
6. [B-type natriuretic peptide (BNP) levels and the effects of carvedilol on BNP levels in juvenile rats with right heart failure]. An JD, Liang F, Feng S. Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):571-6. PubMed ID: 19650993 [Abstract] [Full Text] [Related]
7. Metabolic characterization of volume overload heart failure due to aorto-caval fistula in rats. Melenovsky V, Benes J, Skaroupkova P, Sedmera D, Strnad H, Kolar M, Vlcek C, Petrak J, Benes J, Papousek F, Oliyarnyk O, Kazdova L, Cervenka L. Mol Cell Biochem; 2011 Aug; 354(1-2):83-96. PubMed ID: 21465236 [Abstract] [Full Text] [Related]
8. MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart. Wang BW, Wu GJ, Cheng WP, Shyu KG. PLoS One; 2014 Aug; 9(1):e84188. PubMed ID: 24392114 [Abstract] [Full Text] [Related]
9. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. Wei S, Chow LT, Sanderson JE. J Am Coll Cardiol; 2000 Jul; 36(1):276-81. PubMed ID: 10898446 [Abstract] [Full Text] [Related]
11. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Cleland JG, Pennell DJ, Ray SG, Coats AJ, Macfarlane PW, Murray GD, Mule JD, Vered Z, Lahiri A, Carvedilol hibernating reversible ischaemia trial: marker of success investigators. Lancet; 2003 Jul 05; 362(9377):14-21. PubMed ID: 12853194 [Abstract] [Full Text] [Related]
12. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Ruzicka M, Yuan B, Harmsen E, Leenen FH. Circulation; 1993 Mar 05; 87(3):921-30. PubMed ID: 8443912 [Abstract] [Full Text] [Related]
13. Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes. Shyu KG, Ko WH, Yang WS, Wang BW, Kuan P. Cardiovasc Res; 2005 Dec 01; 68(3):405-14. PubMed ID: 16125157 [Abstract] [Full Text] [Related]
14. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration. Yoshikawa E, Marui A, Tsukashita M, Nishina T, Wang J, Muranaka H, Ikeda T, Komeda M. Eur J Cardiothorac Surg; 2010 Feb 01; 37(2):362-7. PubMed ID: 19692266 [Abstract] [Full Text] [Related]
15. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Wallhaus TR, Taylor M, DeGrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK. Circulation; 2001 May 22; 103(20):2441-6. PubMed ID: 11369683 [Abstract] [Full Text] [Related]
16. Revisiting the surgical creation of volume load by aorto-caval shunt in rats. Ocampo C, Ingram P, Ilbawi M, Arcilla R, Gupta M. Mol Cell Biochem; 2003 Sep 22; 251(1-2):139-43. PubMed ID: 14575315 [Abstract] [Full Text] [Related]
17. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F. Am Heart J; 2000 Apr 22; 139(4):596-608. PubMed ID: 10740140 [Abstract] [Full Text] [Related]
18. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure. Ruffolo RR, Feuerstein GZ. Cardiovasc Drugs Ther; 1997 May 22; 11 Suppl 1():247-56. PubMed ID: 9211017 [Abstract] [Full Text] [Related]
19. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol. Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF. Cardiovasc Res; 1992 May 22; 26(5):518-25. PubMed ID: 1359930 [Abstract] [Full Text] [Related]
20. Effect of carvedilol against myocardial injury due to ischemia-reperfusion of the brain in rats. Harima M, Arumugam S, Wen J, Pitchaimani V, Karuppagounder V, Afrin MR, Sreedhar R, Miyashita S, Nomoto M, Ueno K, Nakamura M, Watanabe K. Exp Mol Pathol; 2015 Jun 22; 98(3):558-62. PubMed ID: 25872160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]